mGlide-Care: Partnering with Caregivers to Manage High Blood Pressure
Official title: mGlide-Care: A Partnership With Caregivers to Improve HTN Management in Patients With Cognitive Impairment
Run by University of Minnesota · NCT05850416 · Data updated 2026-11-12
This project will test a smartphone-based blood pressure program, mGlide-Care, to help people with mild cognitive impairment or early Alzheimer's disease and their unpaid family caregivers improve control of high blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 85 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | January 15, 2026 |
| Main results expected | May 30, 2028 |
| Study ends | May 30, 2028 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT05850416 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults with early-stage AD/ADRD or MCI who have uncontrolled hypertension, an established HTN diagnosis, an unpaid family caregiver willing to assist, and access to a smartphone or tablet that can transmit blood pressure readings.
✕Probably not a fit
Patients with severe life-limiting comorbid illness, active illicit drug use, homelessness or inability to complete study tasks, or those without a caregiver or compatible mobile device are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
mGlide-Care adapts an existing mHealth hypertension care model to the needs of people with early-stage AD/ADRD or MCI by explicitly involving unpaid family caregivers in home blood pressure monitoring and communication with clinical teams. In Aim 1 investigators will engage patients, caregivers, primary care providers, geriatricians, and pharmacists to refine the intervention for acceptability and usability. In Aim 2 they will run a feasibility pilot comparing mGlide-Care to usual care in 75 participants with uncontrolled hypertension, with caregivers assisting participants in using smartphone-connected BP monitors. Primary outcomes include feasibility measures and blood pressure control, collected through remote BP transmissions and routine clinical follow-up at the Minneapolis site.
Why it matters
Potential benefit: If successful, mGlide-Care could help people with early AD/MCI and their caregivers achieve better blood pressure control, which may lower risk of stroke and heart disease.
How similar studies have gone: mGlide-Care is adapted from mGlide, and mobile health programs have improved blood pressure control in other populations, but caregiver-mediated HTN management specifically in early AD/ADRD is largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Must meet all criteria * Diagnosed with early stage AD/ADRD or MCI * Have uncontrolled hypertension (HTN) * Have an unpaid, family caregiver * Have established medical diagnosis of hypertension (HTN) * English speaking * Participant or caregiver must have a smartphone or mobile device (e.g. iPad) that can transmit blood pressure (BP) from the BP monitor * Participant and caregiver capable and willing to comply with the entire study protocol * Able to give voluntary written informed consent. Exclusion Criteria: Any of the following will be an exclusion. * Severe comorbid illness including end-stage kidney disease, end-stage liver disease, and life expectancy \<1 year, or if medical complexity of the patient precludes clinical trial participation * Active illicit drug use (e.g. cocaine, methamphetamines, opioids, phencyclidine) since this will interfere with HTN management * Participant and caregiver unable to complete study tasks, including are homeless, will leave the country, or will relocate in the next 12 months * Serious psychiatric illness that could interfere with treatment, assessment, or compliance including significant delusional disorders such as schizophrenia and bipolar illness * Unable or unwilling to give consent.
Where it's running
-
Epidemiology Clinical Research Center
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Study coordinator: Kamakshi Lakshminarayan
- Email: mGlideCare@umn.edu
- Phone: 6512085980
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Isometric Handgrip Exercise to Lower Blood Pressure in Pregnant Women
This study tests whether doing isometric handgrip exercises can help lower blood pressure in pregnant women, including those with chronic hypertension.
-
Investigating microcirculation with non-invasive devices in adults with or at risk for CKD
This study tests two non-invasive devices (HEMI and SPG-NINOX) to see how small blood vessels behave in adults with or at risk for chronic kidney disease, hypertension, or type 2 diabetes.
-
Mobile home BP monitoring with coaching after high blood pressure from pregnancy
This program tests whether a home blood pressure monitoring system plus virtual coaching can help midlife women, 10–20 years after a hypertensive pregnancy, manage high blood pressure better than usual care.
-
Low energy availability and high blood pressure in Division I HBCU athletes
This project will test whether not eating enough for heavy training (low energy availability) is linked to higher blood pressure and stiffer arteries in Division I HBCU athletes ages 18–25.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.